Search for content, post, videos

Category

Business article

recipharm
0 COMMENT
126 Views
Recipharm’s latest investment

Twenty years after its founding, Recipharm has established itself as a global life science firm with a solid base in its home country, Sweden and has become an example of a successful Nordic CDMO company. The firm is now setting out to strengthen its Swedish operations further with a new…

arab-health-2017
0 COMMENT
79 Views
Arab Health 2017 – Bigger than ever

  Ola Björkman from Let ’em know has provided us with his impressions from Arab Health 2017. Over 4,000 companies and 130,000 visitors from 160 countries gathered in Dubai this week – a crowded exhibition despite several halls with a total area equivalent to around ten football fields. At first…

oslo cancer cluster
0 COMMENT
95 Views
Reports on the Nordic Life Science Markets

Nordic Life Science Magazine has taken a closer look at the different Nordic country’s life science sectors and provides you with an update of their possibilities, their efforts and their challenges. Read the reports here: A new era for Finnish life science Denmark: A life science standout  Norway: A rising…

ice bucket challenge
0 COMMENT
64 Views
CSR on the agenda

A few years ago, reports indicated that Swedish life science companies did not focus as much on corporate social responsibility issues as other industries did. While larger pharmaceutical and biotechnology corporations have formalized much of what they already were doing into corporate social responsibility (CSR) programs, in the case of…

india
0 COMMENT
113 Views
A land of opportunities

India has emerged as one of the most attractive business and investment destinations in the world. For the past two decades, India has been one of the world’s fastest growing economies. In the early 1990s there was a pervasive reformation of the Indian economy, followed by the deregulation of several…

photo octapharma
0 COMMENT
73 Views
A turn-around for Swedish life science

After some tough years much effort is now being made to strengthen the Swedish life science industry. Sweden has a long tradition of medical research and groundbreaking innovations. The life science industry has yielded innovations, such as the gamma knife, the ultrasound scanner, the artificial kidney and pharmaceuticals like Bricanyl…

photo markus sommers
0 COMMENT
72 Views
A new era for Finnish life science

The Finnish health sector is getting a boost, creating a vital life science industry, where the field of digital health especially is growing at a rapid pace. No countries were spared when the economic crisis hit the entire world back in 2008. Finland took a big hit, and so did…

novozymes
0 COMMENT
98 Views
Denmark: a Life Science Standout

Industry-leaders get where they are by capitalizing on their strengths, whether that is an educated workforce, innovative thinkers, strong public-private partnerships or efficient government. With all these assets plus more, it is no surprise that Denmark has emerged as a world leader in the life sciences and health care. Thanks…

copenhagen
0 COMMENT
65 Views
Denmark: best for business

Forbes Magazine ranks Denmark no. 1 in their global league table “Best Countries for Business”. Just recently, the World Bank ranked Denmark first in Europe in their Doing Business Report, and the Danish Minister for Foreign Affairs, Kristian Jensen, hopes that the recurring international recognition of the Danish business climate…

0 COMMENT
68 Views
HealthCap opens office in Oslo

HealthCap, a life science venture capital firm, has opened an office in Oslo, Norway. The office is located in the newly established incubator in the Oslo Cancer Cluster Innovation Park. “The strong environment created in the dedicated oncology cluster, bringing together all parts of the oncology value chain at the…

Warsaw business district
0 COMMENT
89 Views
Life science opportunities in Poland

With the largest economy in central Europe, Poland is attracting a lot of interest from the Nordic life science industry. The country’s pharmaceutical, biotechnology, clinical trial and medical technology sectors all are expected to keep growing for the next several years. “Poland is a huge market of 38 million people…

agreement
0 COMMENT
62 Views
Orphan Drugs Spur M&A Interest

Thanks to the potential for higher prices, limited competition and favorable regulations, orphan drugs continue to be popular to manufacture and also attractive to buy, and Moody’s predicts they will continue to generate merger and acquistion activity. Nearly half of recent acquisitons involved orphan drugs, or medications that treat serious…

salss 2015
0 COMMENT
58 Views
Pfizer Is Potential Sobi Suitor

Pfizer, Inc. is the potential investor for Swedish Orphan Biovitrum AB (Sobi), Reuters reported last week. Sobi develops medications for rare diseases. In its latest filings the company reported a market value of about $4.3 billion, which makes it attractive to large pharmaceutical companies looking to bolster their pipelines. On…

0 COMMENT
62 Views
Obesity Drug Seeks U.S. Niche

Novo Nordisk is betting its new obestiy drug Saxenda is going to find a comfortable niche in the crowded weight-loss drug market in the U.S., in part because of the company’s existing relationships with many endocrinologists and by targeting morbidly obese patients. Plus, doctors already are familiar with the drug…

0 COMMENT
68 Views
Biopeople Weighs New Voucher Program

The success of a In2Life Sciences voucher is spurring http://www.biopeople.dk Biopeople into working with European partners on setting up a new voucher project. Thanks to a €7000 In2Lifesciences voucher and the introduction to partners Biotrial and Eurosafe in France from Biopeople, Dermtreat was able to move forward with development of a proprietary amphilic electro spun…